Home > Insider Trading > Filing (0001493152-18-008739)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133416	Galectin Therapeutics Inc	GALT	Pharmaceutical Preparations (2834)	043562325

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1453356	10X Fund, L.p.	1230 Peachtree Street, N.e., Suite 2445 Atlanta, GA 30309		No	No	Yes	No
1457247	10X Capital Management, Llc	1230 Peachtree Street, N.e., Suite 2445 Atlanta, GA 30309		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-06-13	60,000	$6.59	2,949,786	No	4	S	Indirect	See footnote
Common Stock	Disposition	2018-06-13	60,000	$7.09	2,889,786	No	4	S	Indirect	See footnote
Common Stock	Disposition	2018-06-13	60,000	$7.47	2,829,786	No	4	S	Indirect	See footnote
Common Stock	Disposition	2018-06-13	28,140	$7.97	2,801,646	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees.
10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.